Skip to main content

Actualités de l'entreprise

SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements

SGD Pharma, announces its goal to become the global market leader in primary pharmaceutical glass packaging. CEO Olivier Rousseau explains that SGD…
Lire

Navigating Sustainability Challenges in the Pharmaceutical Industry: Insights on Glass Packaging and Regulatory Changes

In a recent roundtable hosted by Pharma's Almanac, Olivier Rousseau, the Chief Executive Officer of SGD Pharma, shared his valuable perspectives on…
Lire

SGD Pharma's Commitment to Fighting Global Warming and Biodiversity Conservation: A Journey with the Zhanjiang Mangrove Wetland Conservation Federation

SGD Pharma is committed to fight global warming. Our decarbonization strategy and our goal to reduce CO2 scope 1 and 2 emissions (-35% in 2030 and…
Lire

New launch of Sterinity ISO vials 10H and 20H

In response to market demand, we have further expanded our Sterinity range of Ready-To-Use (RTU) Type I molded glass vials, with the addition of 10ml…
Lire

EUROPEAN CONTAINER GLASS FEDERATION NEW LEADERSHIP TEAM APPOINTED AT FLACONNAGE BOARD OF DIRECTORS

Brussels, 4th December 2023 -FEVE – the European Federation of glass packaging makers – announced the new chairmanship for the Flaconnage Board of…
Lire

Pharmaceutical Manufacturer - An Interview With Olivier Rousseau

SGD Pharma has been a leader in the moulded glass packaging market for a signifi cant number of years. Central to their vision and plan is a…
Lire